These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30347490)

  • 21. Effect of a Roux-en-Y gastric bypass on the pharmacokinetics of oral morphine using a population approach.
    Lloret-Linares C; Hirt D; Bardin C; Bouillot JL; Oppert JM; Poitou C; Chast F; Mouly S; Scherrmann JM; Bergmann JF; Declèves X
    Clin Pharmacokinet; 2014 Oct; 53(10):919-30. PubMed ID: 25141973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Roux-En-Y Gastric Bypass in the Pharmacokinetics of (R)-Carvedilol and (S)-Carvedilol.
    Yamamoto PA; Cristofoletti R; Vozmediano V; de Gaitani CM; da Silva RM; Kemp R; Sankarankutty AK; Salgado Junior W; Santos JSD; de Moraes NV
    J Clin Pharmacol; 2023 Jul; 63(7):838-847. PubMed ID: 36854819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of weight regain in patients who underwent Roux-en-Y gastric bypass surgery.
    Shantavasinkul PC; Omotosho P; Corsino L; Portenier D; Torquati A
    Surg Obes Relat Dis; 2016 Nov; 12(9):1640-1645. PubMed ID: 27989521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability in repeat serum etonogestrel concentrations among contraceptive implant users during the steady-release pharmacokinetic period.
    Lazorwitz A; Sheeder J; Teal S
    Contraception; 2022 Apr; 108():65-68. PubMed ID: 34973207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Aquilante CL; Sheeder J; Guiahi M; Teal S
    Contraception; 2019 Jul; 100(1):37-41. PubMed ID: 30980827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lisdexamfetamine Pharmacokinetic Comparison Between Patients Who Underwent Roux-en-Y Gastric Bypass and Nonsurgical Controls.
    Steffen KJ; Mohammad AS; Roerig JL; Mitchell JE; Nelson C; Orcutt M; Zhang W; Erickson AL; Elmquist WF
    Obes Surg; 2021 Oct; 31(10):4289-4294. PubMed ID: 34291361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resting energy expenditure after Roux-en Y gastric bypass surgery.
    Wilms B; Ernst B; Thurnheer M; Schmid SM; Spengler CM; Schultes B
    Surg Obes Relat Dis; 2018 Feb; 14(2):191-199. PubMed ID: 29275093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability and bioequivalence of etonogestrel from two oral formulations of desogestrel: Cerazette and Liseta.
    Timmer CJ; Srivastava N; Dieben TO; Cohen AF
    Eur J Drug Metab Pharmacokinet; 1999; 24(4):335-43. PubMed ID: 10892897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational modelling of self-reported dietary carbohydrate intake on glucose concentrations in patients undergoing Roux-en-Y gastric bypass versus one-anastomosis gastric bypass.
    Ashrafi RA; Ahola AJ; Rosengård-Bärlund M; Saarinen T; Heinonen S; Juuti A; Marttinen P; Pietiläinen KH
    Ann Med; 2021 Dec; 53(1):1885-1895. PubMed ID: 34714211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Bariatric Surgery on the Pharmacokinetics Parameters of Amoxicillin.
    Rocha MBS; De Nucci G; Lemos FN; de Albuquerque Lima Babadopulos RF; Rohleder AVP; Fechine FV; Antunes NJ; Mendes GD; do Nascimento DF; de Moraes MO; de Moraes MEA
    Obes Surg; 2019 Mar; 29(3):917-927. PubMed ID: 30415354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations.
    Kuhnz W; Schütt B; Power J; Back DJ
    Arzneimittelforschung; 1992 Sep; 42(9):1139-41. PubMed ID: 1445482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.
    Robert M; Espalieu P; Pelascini E; Caiazzo R; Sterkers A; Khamphommala L; Poghosyan T; Chevallier JM; Malherbe V; Chouillard E; Reche F; Torcivia A; Maucort-Boulch D; Bin-Dorel S; Langlois-Jacques C; Delaunay D; Pattou F; Disse E
    Lancet; 2019 Mar; 393(10178):1299-1309. PubMed ID: 30851879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four years' follow-up changes of physical activity and sedentary time in women undergoing roux-en-Y gastric bypass surgery and appurtenant children.
    Sellberg F; Willmer M; Tynelius P; Berglind D
    BMC Surg; 2017 Dec; 17(1):133. PubMed ID: 29228941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutrient deficiency and obstetrical outcomes in pregnant women following Roux-en-Y gastric bypass: A retrospective Danish cohort study with a matched comparison group.
    Hammeken LH; Betsagoo R; Jensen AN; Sørensen AN; Overgaard C
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():56-60. PubMed ID: 28732251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in serum ghrelin predict weight loss after Roux-en-Y gastric bypass in rats.
    Stylopoulos N; Davis P; Pettit JD; Rattner DW; Kaplan LM
    Surg Endosc; 2005 Jul; 19(7):942-6. PubMed ID: 15920683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART.
    Neary M; Chappell CA; Scarsi KK; Nakalema S; Matovu J; Achilles SL; Chen BA; Siccardi M; Owen A; Lamorde M
    J Antimicrob Chemother; 2019 Oct; 74(10):3003-3010. PubMed ID: 31299074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating Apolipoprotein A-IV presurgical levels are associated with improvement in insulin sensitivity after Roux-en-Y gastric bypass surgery.
    Rao R; Roche A; Febres G; Bessler M; Tso P; Korner J
    Surg Obes Relat Dis; 2017 Mar; 13(3):468-473. PubMed ID: 27986588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic bioequivalence, safety and acceptability of Ornibel
    Algorta J; Diaz M; de Benito R; Lefebvre M; Sicard E; Furtado M; Regidor PA; Ronchi C
    Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):429-438. PubMed ID: 29336615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diet-induced thermogenesis in postoperatve Roux-en-Y gastric bypass patients with weight regain.
    Cardeal MA; Faria SL; Faria OP; Facundes M; Ito MK
    Surg Obes Relat Dis; 2016 Jun; 12(5):1098-1107. PubMed ID: 27178617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity.
    Ahmad NN; Pfalzer A; Kaplan LM
    Int J Obes (Lond); 2013 Dec; 37(12):1553-9. PubMed ID: 23567924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.